South and Central America Typhoid Fever Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Vaccine Type (Live Attenuated Vaccine, Capsular Polysaccharide Vaccines, Conjugate Vaccine and Others) and Route of administration (Oral an

South and Central America Typhoid Fever Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Vaccine Type (Live Attenuated Vaccine, Capsular Polysaccharide Vaccines, Conjugate Vaccine and Others) and Route of administration (Oral and Injectable)and Country

The South and Central America typhoid fever vaccines market is expected to reach US$ 24.37 million by2027 from US$ 13.79 million in 2019. The market is estimated to grow ata CAGR of 7.7% from 2020 to 2027.

The growth of the marketcan be attributed to increasing prevalence of typhoid in the South and Central America (SCAM) region.Also, growing healthcare industry in South and Central America is likely to create growth opportunities for the market. On the other hand, the market is likely to have a negative impact due to risks associated with typhoid fever vaccines.

The growing healthcare industry in South and Central America is likely to create growth opportunities for the market. Brazil is one of the largest healthcare markets in the region. In 2018, Brazil ranked among the top six markets in size for drugs and pharmaceuticals sales of US$28.4 billion including taxes. Similarly, in 2018, the country also increased its imports by 9.7% in medicines and raw materials, reaching US$7.2 billion. Furthermore, as per the International Trade Administration, in Argentina, healthcare expenditures account for 9% of the GDP, which is among the highest in the region.Thus, growing healthcare industry is likely to create opportunities for the market to grow.

Based on vaccine type, the South and Central Americatyphoid fever vaccines market was segmented intolive attenuated vaccine, capsular polysaccharide vaccines, conjugate vaccine, and others. The capsular polysaccharide vaccines segment held the largest share of the market in 2019. However, the live attenuated vaccine segment is estimated to register the highest CAGR in the market during the forecast period.Based on route of administration, the South and Central Americatyphoid fever vaccines market was segmented into oral and injectable.

Some of the major secondary sources for South and Central Americatyphoid fever vaccines marketincluded in the report are Gavi, The Vaccine Alliance, Centers for Disease Control and Prevention, International Trade Administration, and World Health Organization,amongothers.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America typhoid fever vaccines market.

Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the South and Central America typhoid fever vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.